Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Erba
Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates
Cancer Research
Cancer Research
Oncology
Investigating Large Igneous Province Formation and Associated Paleoenvironmental Events: A White Paper for Scientific Drilling
Scientific Drilling
Power Technology
Mechanical Engineering
Energy Engineering
Related publications
Activity of EGFR, mTOR and PI3K Inhibitors in an Isogenic Breast Cell Line Model
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination With Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Antitumor Activity of MEK and PI3K Inhibitors Against Malignant Pleural Mesothelioma Cells in Vitro and in Vivo
International Journal of Oncology
Cancer Research
Oncology
Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Antioxidant, Metabolic and Antitumor Activity of Triterpenoids Combination With Cytostatics
International Journal of Pharmacy and Pharmaceutical Sciences
Pharmacology
Pharmaceutical Science
